Clinical Trials Logo

Maroteaux-Lamy Syndrome clinical trials

View clinical trials related to Maroteaux-Lamy Syndrome.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT02156674 Terminated - Clinical trials for Maroteaux-Lamy Syndrome

Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome

Start date: January 26, 2016
Phase: N/A
Study type: Interventional

This is a single center study in which Naglazyme® will be given weekly for two years in patients with Maroteaux-Lamy syndrome, also known as mucopolysaccharide VI (MPS VI), who have previously been treated with an allogeneic transplant.

NCT ID: NCT00668564 Terminated - Clinical trials for Niemann-Pick Disease, Type C

Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism

Start date: March 2008
Phase: Phase 2
Study type: Interventional

The primary objective of this clinical trial is to evaluate the ability to achieve and sustain donor engraftment in patients with lysosomal and peroxisomal inborn errors of metabolism undergoing hematopoietic stem cell transplantation (HCT).